8MM Respiratory Syncytial Virus Prophylaxis Market Drug Analysis Report: Prophylactic Options to Continue to Diversify Due to Strength of Late-Stage Pipeline - Forecast to 2030
December 20, 2024 10:05 ET
|
Research and Markets
Dublin, Dec. 20, 2024 (GLOBE NEWSWIRE) -- The "Respiratory Syncytial Virus Prophylaxis: Eight-Market Drug Forecast and Market Analysis - Update" report has been added to ResearchAndMarkets.com's...
Myositis Therapeutics Market Report 2024: Comprehensive Insights about 18+ Companies and 20+ Pipeline Drugs
December 18, 2024 09:37 ET
|
Research and Markets
Dublin, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The "Myositis - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...
FcRn Inhibitor Market Size, Target Population, Competitive Landscape & Forecast to 2034 - Immunovant Advances FcRn Inhibitor Pipeline with Promising Results and FDA Green Light for Pivotal Trial
December 11, 2024 06:25 ET
|
Research and Markets
Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "FcRn Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034" report has been added to ResearchAndMarkets.com's...
Biopharmaceutical Fermentation Systems Industry Report 2024 - Upstream Products Segment is Forecast to Reach US$6.5 Billion by 2030 with a CAGR of a 3.7%
December 09, 2024 09:32 ET
|
Research and Markets
Dublin, Dec. 09, 2024 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Fermentation Systems - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for...
Chronic Pseudomonas Aeruginosa Pulmonary Infections Pipeline Insight 2024 - Pipeline Drug Profiles, Including Clinical and Non-clinical Stage Products
December 06, 2024 04:13 ET
|
Research and Markets
Dublin, Dec. 06, 2024 (GLOBE NEWSWIRE) -- The "Chronic Pseudomonas Aeruginosa Pulmonary Infections - Pipeline Insight, 2024" has been added to ResearchAndMarkets.com's offering.This report provides...
Single Domain Antibody Platform Market to Reach US$ 86 Million by 2034, Expanding at a CAGR of 10.1% | Fact.MR Report
December 04, 2024 07:30 ET
|
FACT.MR
Rockville, MD, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Increasing investments in healthcare research and development are leading to the increased adoption of single domain antibody platforms due to their...
Combination Antibody Therapy Strategic Research Report 2024: Global Market Value to Reach $443 Billion by 2030 - Increased Use in Oncology Generates Demand for Multi-targeted Antibody Treatments
December 02, 2024 06:42 ET
|
Research and Markets
Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Combination Antibody Therapy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Graves' Disease Pipeline Drug Research Report 2024 Featuring Viridian Therapeutics, Immunovant Sciences, Apitope International, Sling Therapeutics, and Novartis
December 02, 2024 05:23 ET
|
Research and Markets
Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Graves' Disease - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.The report outlays comprehensive insights...
Immune Thrombocytopenia (ITP) Industry Analysis and Forecast 2020-2034: ITP Market Trends, Epidemiology, Treatment Dynamics, Geographic Opportunities, Emerging Therapies, and Access Challenges
December 02, 2024 04:07 ET
|
Research and Markets
Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Immune Thrombocytopenia Market Insights, Epidemiology, and Market Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. This...
Monoclonal Antibody Collaboration and Licensing Analysis Report 2024 with Directory of 639 Deals Signed Since 2019 by Company A-Z, Deal Type and Therapeutic Target
November 26, 2024 06:29 ET
|
Research and Markets
Dublin, Nov. 26, 2024 (GLOBE NEWSWIRE) -- The "Monoclonal Antibody Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering. Fully revised and...